Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma

PURPOSE: To assess the feasibility and safety of percutaneous intraductal radiofrequency ablation (RFA) for unresectable Bismuth types III and IV hilar cholangiocarcinoma. RESULTS: Percutaneous intraductal RFA combined with metal stent placement was successful in all patients without any technical p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu, Cui, Wei, Fan, Wenzhe, Zhang, Yingqiang, Yao, Wang, Huang, Kunbo, Li, Jiaping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288231/
https://www.ncbi.nlm.nih.gov/pubmed/27322076
http://dx.doi.org/10.18632/oncotarget.10116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288231/
https://www.ncbi.nlm.nih.gov/pubmed/27322076
http://dx.doi.org/10.18632/oncotarget.10116

Ejemplares similares